Field & Main Bank’s Sanofi SNY Stock Holding History

Field & Main Bank’s Portfolio SNY Stock Details SNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-101	Closed	-$5K	–	328
2022 Q2	$5K	Buy	+101	New	+$5.36K	﹤0.01%	279

Other funds holding SNY

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Field & Main Bank's SNY Position: Q3 2022 in Review

Field & Main Bank sold out of Sanofi (SNY) in Q3 2022, closing a stake of 101 shares — an estimated $5K sold.

Field & Main Bank first reported a position in SNY in Q2 2022 and held it in 1 quarter. The position peaked at $5K in Q2 2022. 587 funds tracked by Wall St. Rank hold SNY as of Q3 2022.

Field & Main Bank reported no remaining Sanofi position as of Q3 2022 after selling out during the quarter.
Field & Main Bank sold 101 Sanofi shares in Q3 2022, an estimated $5K.
Field & Main Bank first reported a position in Sanofi in Q2 2022 and held it in 1 quarter.
Field & Main Bank's Sanofi position peaked at $5K in Q2 2022.
587 funds tracked by Wall St. Rank held Sanofi as of Q3 2022.

Based on Field & Main Bank's 13F filing for Q3 2022, filed 25 Oct 2022.